Difference between revisions of "TDRKH-AS1"
Jiabao Cao (talk | contribs) |
Jiabao Cao (talk | contribs) (→Expression) |
||
| Line 7: | Line 7: | ||
===Expression=== | ===Expression=== | ||
| − | Co-expression analysis of EZH2 in TCGA data and comparison with ChIP sequencing results show that RP11-98D18.9 is positively correlated with EZH2.<ref name="ref1" /> | + | [[File:RP11-307C12.11 coexpre.jpg|right|thumb|400px|'''Co-expression analysis of EZH2'''<ref name="ref1" />.]] |
| + | Co-expression analysis of EZH2 in TCGA data and comparison with ChIP sequencing results show that RP11-98D18.9 is positively correlated with EZH2.<ref name="ref1" /> | ||
==Labs working on this lncRNA== | ==Labs working on this lncRNA== | ||
Latest revision as of 02:09, 10 November 2017
Annotated Information
Name
TDRKH-AS1:TDRKH antisense RNA 1
RP11-98D18.9[1]
Expression
Co-expression analysis of EZH2[1].
Co-expression analysis of EZH2 in TCGA data and comparison with ChIP sequencing results show that RP11-98D18.9 is positively correlated with EZH2.[1]
Labs working on this lncRNA
- Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
